AngioDynamics, Inc. (ANGO) vs STAAR Surgical Company (STAA)
- AngioDynamics, Inc. ANGO 11.25 −2.85%
- STAAR Surgical Company STAA 21.27 −4.45%
AngioDynamics, Inc. and STAAR Surgical Company are both Medical Instruments & Supplies companies. STAAR Surgical Company is the larger, with a market value of $1.1B against $487.0M — 2.3× the size. AngioDynamics, Inc. has negative trailing earnings, so its P/E is not meaningful; STAAR Surgical Company trades at 304×. STAAR Surgical Company grew revenue faster over the last twelve months: 51.3% against 8.20%. STAAR Surgical Company has the higher net margin (1.13% vs −10.1%) and the higher return on invested capital (4.67% vs −17.6%). Across the 17 metrics below, STAAR Surgical Company leads on 11 and AngioDynamics, Inc. on 6.
Valuation
Profitability
| Metric | ANGO | STAA | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 55.65% | 76.62% | 54.29% |
| Operating margin | (11.24%) | 4.04% | 1.07% |
| Net margin | (10.12%) | 1.13% | (1.61%) |
| Free cash flow margin | 0.44% | (1.99%) | 1.08% |
| Return on equity | (19.21%) | 1.09% | (1.32%) |
| Return on assets | (12.98%) | 0.84% | 0.00% |
| Return on invested capital | (17.58%) | 4.67% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack